C60 fullerenes (Roche)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameC60 fullerenes (Roche)
Drug Alias Namebuckminsterfullerenes (Roche)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree radicals scavengers
TargetsFree radicals
Therapy Area/IndicationsNerve DegenerationCraniocerebral TraumaStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRoche Holding Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoche Holding Ag
Active IndicationsN/A
Inactive IndicationsNerve DegenerationCraniocerebral TraumaStroke

Other Information

ATC CodeN/A
Related LinksN/A